X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2022/07/26/2486010/33692/en/AXIM-Biotechnologies-Enhances-IgE-Testing-Capabilities-Responds-to-Global-Warming-s-Impact-on-Allergy-Season.html
https://www.globenewswire.com/news-release/2022/07/12/2478178/33692/en/AXIM-Biotechnologies-Publishes-Study-Highlighting-Neutralizing-Antibody-Levels-of-Poor-Vaccine-Responders-with-a-Third-COVID-19-Vaccine-Dose.html
https://www.globenewswire.com/news-release/2022/06/02/2455281/33692/en/AXIM-Launches-New-Eye-Care-Website-Establishes-Platform-for-Commercialization.html
https://www.globenewswire.com/news-release/2022/05/24/2449460/33692/en/AXIM-Biotechnologies-Completes-Optimization-of-Only-FDA-Cleared-IgE-Rapid-Diagnostics-Test-In-House-Manufacturing-Lowers-Cost-and-Eliminates-Supply-Chain-Expenditures.html
https://www.globenewswire.com/news-release/2022/05/10/2439840/33692/en/AXIM-Biotechnologies-Develops-Novel-Tear-Sample-Collector-System-Files-Patent-Application.html
https://www.globenewswire.com/news-release/2022/04/27/2430303/33692/en/AXIM-Develops-Quantitative-Rapid-Diagnostic-Test-for-Lacritin-Now-Boasts-Four-Dry-Eye-Disease-Point-of-Care-Biomarker-Tests.html
https://www.globenewswire.com/news-release/2022/04/19/2424447/33692/en/AXIM-Biotechnologies-CEO-Issues-Letter-to-Shareholders.html
https://www.globenewswire.com/news-release/2022/03/08/2399020/33692/en/AXIM-Biotech-Develops-Rapid-Quantitative-Tear-Test-for-MMP-9-An-Inflammatory-Biomarker-of-Dry-Eye-Disease.html
https://www.globenewswire.com/news-release/2022/03/07/2398046/33692/en/AXIM-Biotech-Launches-For-Research-Use-Only-Sales-for-its-COVID-19-Neutralizing-Antibody-Test.html
Market Place
Share 
